Arkolith/Insider Trading/CRVO/Form 4

Winton Matthew

Chief Commercial and BusinessCervoMed Inc. (CRVO) · full profile →Form 4 · filed Nov 19, 2025
Net Buying
Open-Market Buys
$41K
Open-Market Sells
$0
Net Open-Market Flow
$41K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2025Buy(P)2K$7.95$12K15K
Nov 17, 2025Buy(P)4K$8.43$30K14K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-035655) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML